ArticleBMC pediatrics2024
A retrospective analysis of clinical characteristics and outcomes of pediatric fulminant myocarditis.
Article in BMC pediatrics, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. An erratum has been issued. Cited by 12 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
12 citing papers in PubMed.
- [Early warning indicators and prognosis in children with fulminant myocarditis treated with extracorporeal membrane oxygenation].Zhongguo dang dai er ke za zhi = Chinese journal of contemporary pediatrics · 2026Article
- Pediatric Myocarditis: Challenges in Diagnosis and Treatment.Paediatric drugs · 2026Review
- Machine learning-based mortality prediction for pediatric fulminant myocarditis using cytokine profiles.Scientific reports · 2026Article
- Clinical and virological impacts of human parvovirus B19 epidemics on fulminant myocarditis in childhood.BMC pediatrics · 2026Article
- Correction: A retrospective analysis of clinical characteristics and outcomes of pediatric fulminant myocarditis.BMC pediatrics · 2025Article
- Beyond the consult: Outcomes following pediatric VAD referral.JHLT open · 2025Article
- New Systemic Inflammatory Indices as Predictors of Fulminant Myocarditis in Children.Diagnostics (Basel, Switzerland) · 2025Article
- The brand-new predictor index of fulminant process in patients with acute myocarditis: hemoglobin, albumin, lymphocyte and platelet (HALP) score.Frontiers in nutrition · 2025Article
- Comparative global burden of ischemic heart disease and myocardial disease attributable to non-optimal temperatures, 1990-2021: an analysis based on GBD 2021.Frontiers in public health · 2025Article
- Early clinical predictors of fulminant myocarditis in pediatric patients: a retrospective cohort study.Frontiers in cardiovascular medicine · 2025Article
- Outbreak of Acute Fulminant Myocarditis in Children in Campania Region, Italy: A Case Series.Children (Basel, Switzerland) · 2024Article
- Serum hsa-miR-21 expression and its clinical value in pediatric patients with fulminant myocarditis.Jornal de pediatriaArticle
Corrections and comments
- Erratum issued
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundThe study aimed to explore clinical indicators that can predict the prognosis of children with acute fulminant myocarditis (AFM) through a retrospective analysis.
methodsA retrospective analysis was conducted on the clinical indices of 79 children diagnosed with AFM and hospitalized from March 2013 to March 2023. Relevant demographic and clinical data, including symptoms at admission, laboratory results, and outcomes were extracted to identify factors associated with in-hospital mortality.
resultsA total of 79 children with AFM were analyzed. The survival group (n = 61) had a longer median hospital stay and higher medical expenses compared to the death group (n = 18). Significant differences in the levels of left ventricular ejection fraction (LVEF)(P < 0.001), myoglobin (MYO)(P < 0.001), aspartate aminotransferase (AST)(P < 0.001), lactate dehydrogenase (LDH)(P = 0.004), B-type natriuretic peptide (BNP)(P = 0.005), arterial potential hydrogen (PH)(P < 0.001), bicarbonate (HCO
conclusionsSevere myocardial injury (AST > 194.00 U/L, LDH > 637.50 U/L, MYO > 265.75 µg/L, BNP > 1738.50 ng/L), acidosis (PH < 7.29, HCO
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.